EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES

EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES

We have conducted a study of a novel monoclonal A3 antibody raised by means of hybridoma biotechnology. The study was performed with malignant cells of the patients with various lymphoproliferative disorders, and persons with nonmalignant diseases, as compared with intact lymphocytes from healthy pe...

Full description

Bibliographic Details
Main Authors:	N. L. Deineko, T. I. Bulycheva, A. M. Kovrigina, A. A. Grigoriyv
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2014-11-01
Series:	Медицинская иммунология
Subjects:	antigen a3 lymphoproliferative diseases nucleoli immunocytochemistry
Online Access:	https://www.mimmun.ru/mimmun/article/view/730

Similar Items

The diagnosis of lymphoproliferative diseases /
by: Gatter, Kevin 534567
Published: (c201)

Histopathological and Clinical Features of Methotrexate-Associated Lymphoproliferative Disorders and Post-Transplant Lymphoproliferative Disorders
by: Preeyawat Ngamdamrongkiat, et al.
Published: (2022-09-01)

EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS
by: Pietro Tralongo, et al.
Published: (2024-04-01)

Nucleolar number variation in Fritillaria (Liliaceae) taxa from Greece
by: Sofia Samaropoulou, et al.
Published: (2023-04-01)

Chimeric antigen receptor T-cell therapy for refractory post-transplant lymphoproliferative disorder after lung transplantation
by: Kaleb Veit, DO, et al.
Published: (2024-08-01)

X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
by: Takeo Mukai, et al.
Published: (2023-09-01)

Lymphoproliferative diseases in primary Sjogren's syndrome
by: V. i. Vasiljev, et al.
Published: (2022-11-01)

Autoimmune Lymphoproliferative Syndrome (ALPS): A Case Report
by: Yazan S. Mousa
Published: (2016-12-01)

Lymphoproliferative Syndrome in Pediatrist and Infectiologist Practice
by: E. N. Simovanyan, et al.
Published: (2010-06-01)

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
by: Daniela Capello, et al.
Published: (2009-11-01)

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
by: Gianluca Gaidano, et al.
Published: (2009-11-01)

Issue of predicting the risk of thromboembolic complications in patients with lymphoproliferative diseases
by: S. V. Ignatiev, et al.
Published: (2022-04-01)

Utility of CD200 expression by flow cytometry in lymphoproliferative disorders and plasma cell dyscrasias
by: Pavuluri Divya, et al.
Published: (2023-01-01)

Investigation of HoxB3 and Growth Factors Expression in Placentas of Various Gestational Ages
by: Ilze Kreicberga, et al.
Published: (2021-12-01)

HUMAN HERPESVIRUS 8 AND LYMPHOPROLIFERATIVE DISEASES
by: Maria Luisa Calabrò, et al.
Published: (2018-11-01)

Thrombodynamics test efficacy in predicting thromboembolic complications in patients with lymphoproliferative disorders
by: S. V. Ignatyev, et al.
Published: (2024-09-01)

Color Atlas of Immunocytochemistry in Diagnostic Cytology [electronic resource]: /
by: 396889 Ganjei-Azar, Parvin, et al.
Published: (2007)

Pulmonary comorbidity in chronic lymphoproliferative diseases: realities of the problem in the Dnipro region
by: K.Yu. Gashynova, et al.
Published: (2021-12-01)

Epstein Barr Virus-Positive Lymphoproliferative Disorder Following Lymphodepletion for MAGE A4 Adoptive Cellular Therapy in a Patient with Synovial Sarcoma: A Case Report
by: Maggie Zhou, et al.
Published: (2023-09-01)

LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
by: Eva Eliassen, et al.
Published: (2018-05-01)

A rare case of three distinct Epstein-Barr virus associated lymphoproliferative disorders over sixteen years of human immunodeficiency virus infection
by: Hamdy M.A. Ahmed, et al.
Published: (2017-06-01)

Dysregulation of FBW7 in malignant lymphoproliferative disorders
by: Xin Wan, et al.
Published: (2022-11-01)

Diagnosing adult and pediatric extrapulmonary tuberculosis by MPT64 antigen detection with immunohistochemistry and immunocytochemistry using reproduced polyclonal antibodies
by: Ole Magnus Bjørgaas Helle, et al.
Published: (2024-05-01)

Predictive risk factors for the development of diseases with lymphoproliferative syndrome in children
by: R. F. Makhmutov
Published: (2021-10-01)

RAS-associated autoimmune lymphoproliferative disorder: A case report and literature review
by: JIANG Jian, BU Xiaojie, ZHANG Qiuye, SUN Lirong, ZHAO Yanxia
Published: (2024-10-01)

Hydroa vacciniforme lymphoproliferative disorder：a case report
by: ZHU Xia, JIN Jingjing, WANG Xin, MIAO Fei, MA Jiexian, ZHANG Jiechen, XIAO Li
Published: (2023-12-01)

Evaluation of Nuclear Parameters in Relation to Regional Lymph Node Involvement in Oral Squamous Cell Carcinoma: A Cytomorphometric Study
by: Vahid Karbalaee Khiavi, et al.
Published: (2023-01-01)

HHV-8 and EBV Positive Lymphoproliferative Disease: A Challenging Case
by: Göksenil BÜLBÜL, et al.
Published: (2022-05-01)

First Report of an SH2D1A Mutation Associated with X-Linked Lymphoproliferative Disease in Turkey
by: Selman Kesici, et al.
Published: (2018-08-01)

Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma
by: Zühre Kaya, et al.
Published: (2021-06-01)

Hepatic and lung methotrexate-associated polymorphic lymphoproliferative disorders arising during postoperative follow-up of renal cell carcinoma: a case report
by: Yoshi Miyamoto, et al.
Published: (2023-12-01)

Acquired Angioedema Associated with Lymphoproliferative Disorders
by: Jun Yen Ng, et al.
Published: (2024-02-01)

Late Onset Epstein Barr Virus Seropositive Posttransplant Lymphoproliferative Disorder in Two Renal Transplant Receivers
by: Saime Paydaş, et al.
Published: (2013-09-01)

Lymphoproliferative disorder during temozolomide therapy; a representative case of a formidable complication and management challenges
by: Daisuke Sato, et al.
Published: (2023-06-01)

The fragile X proteins’ enigma: to be or not to be nucleolar
by: Edouard W. Khandjian, et al.
Published: (2024-08-01)

Primary Cutaneous CD4 Small/Medium T-Cell Lymphoproliferative Disorder Following COVID-19 Vaccination—What Do We Know about Lymphoproliferative Disorders and Cutaneous Lymphomas after COVID-19 Vaccination? A Report of an Atypical Case and a Review of the Literature
by: Francisco Javier De la Torre-Gomar, et al.
Published: (2024-03-01)

Clinical features and prognosis of chronic natural killer cell lymphoproliferative disorders
by: Dong-lin Liu, et al.
Published: (2024-12-01)

A case of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder
by: Qingyu Hong, et al.
Published: (2023-01-01)

Primary central nervous system post-transplant lymphoproliferative Disorder in a lung transplant recipient despite reduction of immunosuppression
by: K Afshar, et al.
Published: (2025-02-01)

Utility of BerEp4/calretinin and desmin/epithelial membrane antigen (EMA) dual immunocytochemical staining in effusion cytology
by: Anders Hjerpe, et al.
Published: (2023-03-01)